Medical Security System
International experience and enlightenment of short-term payment for innovative medical technology under the DRG payment
Huang Yanhong, Guo Jiayi, Zhang Hongyi, Yuan Jianlie, Zhang Junlong, Jin Ni
Published 2022-09-02
Cite as Chin J Hosp Admin, 2022, 38(9): 649-652. DOI: 10.3760/cma.j.cn111325-20220525-00475
Abstract
China has entered the task stage of comprehensive medical insurance payment reform, but there are problems restricting the development of innovative medical technology in the reform of diagnosis-related groups(DRG) payment system. The author introduced the international definition and scope of innovative medical technology, and summarized the preconditions and payment policy of short-term payment of innovative medical technology under the DRG payment system; And put forward suggestions in line with China′s actual situation, including clarifying the definition of innovative medical technology, setting access conditions for additional payment or actual payment, setting up special transition funds for high-value innovative drugs, clarifying the payment amount of innovative medical technology, and formulating payment strategies for innovative medical technology.
Key words:
Diagnosis-related groups; Innovative medical technology; Short-term payment; Cost threshold; High-value innovative drugs
Contributor Information
Huang Yanhong
Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua 321000, China
Guo Jiayi
Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua 321000, China
Zhang Hongyi
Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua 321000, China
Yuan Jianlie
Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua 321000, China
Zhang Junlong
Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua 321000, China
Jin Ni
Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua 321000, China
